Loading...
•
Mar 31, 2024
Ekso Bionics Q1 2024 Earnings Report
Ekso Bionics reported first quarter 2024 financial results, showing a decrease in revenue but an increase in gross margin.
Key Takeaways
Ekso Bionics reported a revenue of $3.8 million for Q1 2024, compared to $4.1 million in the same period last year. The company's gross margin increased to 52%, and the net loss decreased to $3.4 million, or $0.20 per share.
Revenue was $3.8 million, down from $4.1 million in the same quarter of the previous year.
Gross profit reached $2.0 million, with a gross margin of approximately 52%.
Net loss applicable to common stockholders was $3.4 million, or $0.20 per share.
Cash and restricted cash stood at $8.8 million as of March 31, 2024.
Ekso Bionics
Ekso Bionics
Forward Guidance
Ekso Bionics is focused on developing the market for Indego Personal and strengthening relationships with network operators for Enterprise devices.